Modelling and simulation: questions and answers

Table of contents

The European Medicines Agency's (EMA) provides an overview of its position on specific issues related to modelling and simulation in the form of questions and answers (Q&As).

Users should read the Q&As in conjunction with the relevant scientific guidelines.

The Committee for Medicinal Products for Human Use (CHMP) and the Paediatric Committee (PDCO) may seek the input of the Modelling and Simulation Working Party (MSWP) to address specific questions in relation to modelling and simulation.

EMA publishes the MSWP's input on this page. The date after each questions refers to when it was first published.

Contact point

Questions about Modelling and Simulation, activities of the MSWP and other general enquiries: Send a question to the European Medicines Agency.



How useful was this page?

Add your rating
16 ratings
3 ratings